Lam, ICH;
Zhang, R;
Man, KKC;
Wong, CKH;
Chui, CSL;
Lai, FTT;
Li, X;
... Wan, EYF; + view all
(2024)
Persistence in risk and effect of COVID-19 vaccination on long-term health consequences after SARS-CoV-2 infection.
Nature Communications
, 15
, Article 1716. 10.1038/s41467-024-45953-1.
Preview |
Text
Man_Persistence in risk and effect of COVID-19 vaccination on long-term health consequences after SARS-CoV-2 infection_VoR.pdf Download (1MB) | Preview |
Abstract
The persisting risk of long-term health consequences of SARS-CoV-2 infection and the protection against such risk conferred by COVID-19 vaccination remains unclear. Here we conducted a retrospective territory-wide cohort study on 1,175,277 patients with SARS-CoV-2 infection stratified by their vaccination status and non-infected controls to evaluate the risk of clinical sequelae, cardiovascular and all-cause mortality using a territory-wide public healthcare database with population-based vaccination records in Hong Kong. A progressive reduction in risk of all-cause mortality was observed over one year between patients with SARS-CoV-2 infection and controls. Patients with complete vaccination or have received booster dose incurred a lower risk of health consequences including major cardiovascular diseases, and all-cause mortality than unvaccinated or patients with incomplete vaccination 30-90 days after infection. Completely vaccinated and patients with booster dose of vaccines did not incur significant higher risk of health consequences from 271 and 91 days of infection onwards, respectively, whilst un-vaccinated and incompletely vaccinated patients continued to incur a greater risk of clinical sequelae for up to a year following SARS-CoV-2 infection. This study provided real-world evidence supporting the effectiveness of COVID-19 vaccines in reducing the risk of long-term health consequences of SARS-CoV-2 infection and its persistence following infection.
| Type: | Article |
|---|---|
| Title: | Persistence in risk and effect of COVID-19 vaccination on long-term health consequences after SARS-CoV-2 infection |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1038/s41467-024-45953-1 |
| Publisher version: | https://doi.org/10.1038/s41467-024-45953-1 |
| Language: | English |
| Additional information: | © 2024 Springer Nature Limited. This article is licensed under a Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/). |
| Keywords: | Disease prevention, Epidemiology, Infectious diseases, SARS-CoV-2 |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy > Practice and Policy |
| URI: | https://discovery-pp.ucl.ac.uk/id/eprint/10187010 |
Archive Staff Only
 |
View Item |
